164 related articles for article (PubMed ID: 36054638)
1. Management of Primary Hyperparathyroidism.
Bilezikian JP; Silverberg SJ; Bandeira F; Cetani F; Chandran M; Cusano NE; Ebeling PR; Formenti AM; Frost M; Gosnell J; Lewiecki EM; Singer FR; Gittoes N; Khan AA; Marcocci C; Rejnmark L; Ye Z; Guyatt G; Potts JT
J Bone Miner Res; 2022 Nov; 37(11):2391-2403. PubMed ID: 36054638
[TBL] [Abstract][Full Text] [Related]
2. Evaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.
Bilezikian JP; Khan AA; Silverberg SJ; Fuleihan GE; Marcocci C; Minisola S; Perrier N; Sitges-Serra A; Thakker RV; Guyatt G; Mannstadt M; Potts JT; Clarke BL; Brandi ML;
J Bone Miner Res; 2022 Nov; 37(11):2293-2314. PubMed ID: 36245251
[TBL] [Abstract][Full Text] [Related]
3. The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Ye Z; Silverberg SJ; Sreekanta A; Tong K; Wang Y; Chang Y; Zhang M; Guyatt G; Tangamornsuksun W; Zhang Y; Manja V; Bakaa L; Couban RJ; Brandi ML; Clarke B; Khan AA; Mannstadt M; Bilezikian JP
J Bone Miner Res; 2022 Nov; 37(11):2351-2372. PubMed ID: 36053960
[TBL] [Abstract][Full Text] [Related]
4. Classical and Nonclassical Manifestations of Primary Hyperparathyroidism.
El-Hajj Fuleihan G; Chakhtoura M; Cipriani C; Eastell R; Karonova T; Liu JM; Minisola S; Mithal A; Moreira CA; Peacock M; Schini M; Silva B; Walker M; El Zein O; Marcocci C
J Bone Miner Res; 2022 Nov; 37(11):2330-2350. PubMed ID: 36245249
[TBL] [Abstract][Full Text] [Related]
5. Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism.
Yao L; Guyatt G; Ye Z; Bilezikian JP; Brandi ML; Clarke BL; Mannstadt M; Khan AA
J Bone Miner Res; 2022 Nov; 37(11):2404-2410. PubMed ID: 36053800
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and Management of Hypoparathyroidism Summary Statement and Guidelines from the Second International Workshop.
Khan AA; Bilezikian JP; Brandi ML; Clarke BL; Gittoes NJ; Pasieka JL; Rejnmark L; Shoback DM; Potts JT; Guyatt GH; Mannstadt M
J Bone Miner Res; 2022 Dec; 37(12):2568-2585. PubMed ID: 36054621
[TBL] [Abstract][Full Text] [Related]
7. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Khan A; Grey A; Shoback D
J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
[TBL] [Abstract][Full Text] [Related]
8. Surgical Aspects of Primary Hyperparathyroidism.
Perrier N; Lang BH; Farias LCB; Poch LL; Sywak M; Almquist M; Vriens MR; Yeh MW; Shariq O; Duh QY; Yeh R; Vu T; LiVolsi V; Sitges-Serra A
J Bone Miner Res; 2022 Nov; 37(11):2373-2390. PubMed ID: 36054175
[TBL] [Abstract][Full Text] [Related]
9. Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.
Silverberg SJ; Clarke BL; Peacock M; Bandeira F; Boutroy S; Cusano NE; Dempster D; Lewiecki EM; Liu JM; Minisola S; Rejnmark L; Silva BC; Walker MD; Bilezikian JP
J Clin Endocrinol Metab; 2014 Oct; 99(10):3580-94. PubMed ID: 25162667
[TBL] [Abstract][Full Text] [Related]
10. Management of parathyroid disorders: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society.
Makras P; Yavropoulou MP; Kassi E; Anastasilakis AD; Vryonidou A; Tournis S
Hormones (Athens); 2020 Dec; 19(4):581-591. PubMed ID: 32297171
[TBL] [Abstract][Full Text] [Related]
11. Etiology and Pathophysiology of Hypoparathyroidism: A Narrative Review.
Pasieka JL; Wentworth K; Yeo CT; Cremers S; Dempster D; Fukumoto S; Goswami R; Houillier P; Levine MA; Pasternak JD; Perrier ND; Sitges-Serra A; Shoback DM
J Bone Miner Res; 2022 Dec; 37(12):2586-2601. PubMed ID: 36153665
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.
Bilezikian JP; Brandi ML; Eastell R; Silverberg SJ; Udelsman R; Marcocci C; Potts JT
J Clin Endocrinol Metab; 2014 Oct; 99(10):3561-9. PubMed ID: 25162665
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelines.
Glendenning P
Intern Med J; 2003 Dec; 33(12):598-603. PubMed ID: 14656235
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).
Weber T; Dotzenrath C; Dralle H; Niederle B; Riss P; Holzer K; Kußmann J; Trupka A; Negele T; Kaderli R; Karakas E; Weber F; Rayes N; Zielke A; Hermann M; Wicke C; Ladurner R; Vorländer C; Waldmann J; Heizmann O; Wächter S; Schopf S; Timmermann W; Bartsch DK; Schmidmaier R; Luster M; Schmid KW; Ketteler M; Dierks C; Schabram P; Steinmüller T; Lorenz K
Langenbecks Arch Surg; 2021 May; 406(3):571-585. PubMed ID: 33880642
[TBL] [Abstract][Full Text] [Related]
16. Asymptomatic primary hyperparathyroidism: new issues and new questions--bridging the past with the future.
Bilezikian JP; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N57-67. PubMed ID: 12412779
[TBL] [Abstract][Full Text] [Related]
17. Asymptomatic primary hyperparathyroidism.
Silverberg SJ; Walker MD; Bilezikian JP
J Clin Densitom; 2013; 16(1):14-21. PubMed ID: 23374736
[TBL] [Abstract][Full Text] [Related]
18. Different PTH response to oral peptone load and oral calcium load in patients with normocalcemic primary hyperparathyroidism, primary hyperparathyroidism, and healthy subjects.
Invernizzi M; Carda S; Righini V; Baricich A; Cisari C; Bevilacqua M
Eur J Endocrinol; 2012 Oct; 167(4):491-7. PubMed ID: 22872468
[TBL] [Abstract][Full Text] [Related]
19. Systems-Level Opportunities in the Management of Primary Hyperparathyroidism: An Informatics-based Assessment.
Dawood NB; Tseng CH; Nguyen DT; Yan KL; Livhits MJ; Leung AM; Yeh MW
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4993-e5000. PubMed ID: 34313755
[TBL] [Abstract][Full Text] [Related]
20. Medical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.
Marcocci C; Bollerslev J; Khan AA; Shoback DM
J Clin Endocrinol Metab; 2014 Oct; 99(10):3607-18. PubMed ID: 25162668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
